NewLimit is a biotechnology company working to radically extend human healthspan. We’re developing medicines to treat age-related diseases by reprogramming the epigenome, a new therapeutic mechanism to restore regenerative potential in aged and diseased cells. We leverage functional genomics, pooled perturbation screening, and machine learning models to unravel the biology of epigenetic aging and disease using experiments of unprecedented scale. All correspondence from NewLimit will come from an @NewLimit.com email address.
- Founded
- 2022
- Company size
- 11-50
- Headquarters
- US
- Funding
- Series B
Hiring activity
- Open roles
- 6
- Posted in the last 30 days
- 6
Updated 6h ago
What NewLimit says about its culture
NewLimit is inventing medicines to add healthy years to people's lives; radically extending human healthspan.
Truth-seeking/realism
“We never want to let pessimism creep into our thinking, and we never want to delude ourselves either. Always seek truth and see reality for what it is.”Source
Concise, clear, energizing, kind communication
“We value communication that is concise, clear, energizing, and kind.”Source
Courage to do the right thing
“We have the courage to do the right thing, even in the face of criticism.”Source
High performance
“We’re a high performance team. We hire and develop the best.”Source
They say people do well here who…
- Hard-working, optimistic builders who can handle an ambitious, difficult mission.
- Team described as hard working and optimistic group of builders.
- People who can operate as high performers, held to high expectations.
Quoted from NewLimit's own website. TeaKo does not verify these claims.
Latest openings
6 open roles at NewLimit. Members see each one.
